{"content":"<li class=\"n-box-item date-title\" data-end=\"1506139199\" data-start=\"1506052800\" data-txt=\"Monday, December 23, 2019\">Friday, September 22, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3297219\" data-ts=\"1506120797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSCO\" target=\"_blank\">CSCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297219-cisco-closes-320m-springpath-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco closes $320M Springpath acquisition</a></h4><ul>   <li>Cisco (<a href=\"http://seekingalpha.com/symbol/CSCO\" target=\"_blank\">CSCO</a> <font color='green'>+2.1%</font>) has <a href=\"https://seekingalpha.com/pr/16948899-cisco-completes-acquisition-springpath\" target=\"_blank\">closed on its $320M-plus acquisition</a> of Springpath, which makes hyperconvergence software.</li>    <li>It had come to a deal to buy its longtime partner a month ago. The two have been working since last year to launch HyperFlex, a fully integrated hyperconverged infrastructure system.</li>    <li>The deal is in cash and assumed equity along with retention incentives.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297219\" data-linked=\"Cisco closes $320M Springpath acquisition\" data-tweet=\"$CSCO - Cisco closes $320M Springpath acquisition https://seekingalpha.com/news/3297219-cisco-closes-320m-springpath-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3297219-cisco-closes-320m-springpath-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297218\" data-ts=\"1506118432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297218-aig-still-sifi-regulatory-panel-not-remove-label\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG still a SIFI, as regulatory panel does not remove label</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a> <font color='red'>-1.7%</font>&nbsp;AH after U.S. regulators <a href=\"http://www.reuters.com/article/us-usa-fsoc-aig/u-s-regulators-stick-with-existing-policy-for-systemic-firms-idUSKCN1BX2WT?il=0\" target=\"_blank\">did not announce any change</a> to existing policy for oversight of \"systematically important financial institutions.\"</li>     <li>The Financial Stability Oversight Council met today to potentially remove the SIFI label, but the panel says it simply &ldquo;discussed an ongoing annual reevaluation of its designation of a non-bank financial company\" - AIG was not identified by name, but the regulators were believed to be <a href=\"https://seekingalpha.com/news/3297016-wsj-u-s-regulators-consider-removing-sifi-designation-aig\" target=\"_blank\">debating easing regulations</a> on the company.</li>     <li>AIG has sold many businesses since the financial crisis, including two Asian life insurance operations and one of the world&rsquo;s biggest aircraft leasing businesses, but it remains the largest commercial insurer in the U.S. and Canada.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297218\" data-linked=\"AIG still a SIFI, as regulatory panel does not remove label\" data-tweet=\"$AIG - AIG still a SIFI, as regulatory panel does not remove label https://seekingalpha.com/news/3297218-aig-still-sifi-regulatory-panel-not-remove-label?source=tweet\" data-url=\"https://seekingalpha.com/news/3297218-aig-still-sifi-regulatory-panel-not-remove-label\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297195\" data-ts=\"1506113237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297195-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/PHO' title='PowerShares Water Resources Portfolio ETF'>PHO</a> <font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a> <font color='green'>+2.1%</font>. <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='green'>+2.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/EPI' title='WisdomTree India Earnings ETF'>EPI</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/SIVR' title='ETFS Physical Silver Trust ETF'>SIVR</a> <font color='red'>-3.5%</font>. <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a> <font color='red'>-3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297195\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$FCG $XLF $PHO - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3297195-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3297195-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297192\" data-ts=\"1506112101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCIX\" target=\"_blank\">DCIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297192-diana-containerships-to-effect-1-forminus-3-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Containerships to effect 1-for-3 reverse split</a></h4><ul>     <li>Diana Containerships (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a>) <font color='red'>-4.7%</font>&nbsp;AH after announcing a <a href=\"https://seekingalpha.com/pr/16948815-diana-containerships-inc-announces-one-three-reverse-stock-split\" target=\"_blank\">one-for-three reverse stock split</a>, effective on or around Sept. 25.</li>     <li>The move will reduce the number of outstanding common shares to ~1.1M shares from 3.2M currently.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297192\" data-linked=\"Diana Containerships to effect 1-for-3 reverse split\" data-tweet=\"$DCIX - Diana Containerships to effect 1-for-3 reverse split https://seekingalpha.com/news/3297192-diana-containerships-to-effect-1-forminus-3-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3297192-diana-containerships-to-effect-1-forminus-3-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297180\" data-ts=\"1506109654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTEGY\" target=\"_blank\">DTEGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297180-filing-sprint-hired-trump-connected-lobbyist-amid-deal-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Filing: Sprint hired Trump-connected lobbyist amid deal talks</a></h4><ul>   <li>With merger discussions apparently heating up between itself and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+1.1%</font>), Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+5.7%</font>) <a href=\"https://www.reuters.com/article/sprint-ma-tmobile-lobbying/sprint-hired-trump-connected-lobbyist-in-early-september-filing-idUSL2N1M3138?feedType=RSS\" target=\"_blank\">hired a lobbying firm</a> with close ties to the Trump administration at the beginning of September, according to a filing.</li>    <li>Shares of the two companies have ridden higher today amid new reports that <a href=\"https://seekingalpha.com/news/3297086-deal-talks-said-heat-sprint-t-mobile\" target=\"_blank\">deal talks have made a major breakthrough</a> on the ownership division of a combined company.</li>    <li>T-Mobile owner Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a>) is <font color='green'>up 1%</font> in U.S. trading; Sprint's owner SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>) is <font color='green'>up 1.2%</font>.</li>    <li>Ballard Partners -- the firm of early Trump supporter Brian Ballard -- was contracted to lobby on \"general government policies and regulations.\" Ballard had opened a Washington outpost of his operation in January.</li>    <li>Sprint had spent $1.2M on Washington lobbying in the first six months of this year, Reuters notes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297180\" data-linked=\"Filing: Sprint hired Trump-connected lobbyist amid deal talks\" data-tweet=\"$DTEGY $DTEGY $SFTBY - Filing: Sprint hired Trump-connected lobbyist amid deal talks https://seekingalpha.com/news/3297180-filing-sprint-hired-trump-connected-lobbyist-amid-deal-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3297180-filing-sprint-hired-trump-connected-lobbyist-amid-deal-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>158&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297178\" data-ts=\"1506109394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBVX\" target=\"_blank\">MBVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297178-mabvax-raises-1_25m-in-direct-offering-shares-down-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MabVax raises $1.25M in direct offering; shares down 12%</a></h4><ul><li>MabVax Therapeutics (<a href='https://seekingalpha.com/symbol/MBVX' title='MABVAX THERAPEUTICS HLDGS'>OTCPK:MBVX</a> <font color='red'>-11.5%</font>) slumps on triple normal volume on the heels of its announced <a href=\"https://seekingalpha.com/pr/16948785-mabvax-therapeutics-holdings-inc-announces-1_25-million-registered-direct-offering\" target=\"_blank\">direct offering </a>of 2M shares of common stock at $0.62 per share yielding gross proceeds of $1.25M.</li><li>Net proceeds will fund the continued clinical development of MVT-5873.</li><li>Yesterday's close was $0.74. The intraday high today was $0.7699.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297178\" data-linked=\"MabVax raises $1.25M in direct offering; shares down 12%\" data-tweet=\"$MBVX $MBVXQ - MabVax raises $1.25M in direct offering; shares down 12% https://seekingalpha.com/news/3297178-mabvax-raises-1_25m-in-direct-offering-shares-down-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3297178-mabvax-raises-1_25m-in-direct-offering-shares-down-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297174\" data-ts=\"1506107244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVLT\" target=\"_blank\">RVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297174-revolution-lightingminus-17-after-cutting-sales-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revolution Lighting -17% after cutting sales guidance</a></h4><ul>     <li>Revolution Lighting (<a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a> <font color='red'>-16.8%</font>) plunges after <a href=\"https://seekingalpha.com/pr/16948424-revolution-lighting-technologies-inc-provides-third-fourth-quarter-updates-revises-full-year\" target=\"_blank\">lowering Q3 and FY 2017 revenue guidance</a> due to the hurricanes in Texas and the southeast U.S. and the slippage of a number of Energy Source division projects in to Q4.</li>     <li>RVLT now sees Q3 revenue of $42M-$44M vs. its prior outlook of $52M-$55M and the $51.7M analyst consensus estimate.</li>     <li>For Q4, RVLT expects revenue of $60M-$65M, a 50% increase over Q3, resulting in full-year revenue of $180M-$185M, below prior guidance of $195M-$205M; the company forecasts full-year EBITDA of ~8% with positive cash flow for the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297174\" data-linked=\"Revolution Lighting -17% after cutting sales guidance\" data-tweet=\"$RVLT - Revolution Lighting -17% after cutting sales guidance https://seekingalpha.com/news/3297174-revolution-lightingminus-17-after-cutting-sales-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3297174-revolution-lightingminus-17-after-cutting-sales-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297170\" data-ts=\"1506106617\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297170-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+21%</font>. WPCS <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies'>MRAM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297170\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$IZEA $HMNY $DCAR - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3297170-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297170-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297167\" data-ts=\"1506104983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVLN\" target=\"_blank\">NVLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297167-novelion-therapeutics-fined-over-units-misleading-performance-metric\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novelion Therapeutics fined over unit&#39;s misleading performance metric</a></h4><ul><li>At issue according to the SEC was Aegerion Pharma (now a subsidiary of Novelion) allegedly exaggerating how many new patients actually filled prescriptions for Juxtapid.</li><li>Neither admitting nor denying the charges, Aegerion has agreed to pay $4.1M, and says the number of unfilled prescriptions was not material.</li><li>Juxtapid is used to treat a rare and potentially life-threatening genetic condition that causes extremely high cholesterol and was priced at approximately $250K-$300K annually per patient in 2013 and 2014.</li><li>Source: <a href=\"http://www.marketwatch.com/story/sec-fines-pharmaceutical-company-41-million-for-misleading-performance-metric-2017-09-22\" target=\"_blank\">Francine McKenna at Marketwatch</a></li><li><a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a>&nbsp;<font color='red'>-1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3297167\" data-linked=\"Novelion Therapeutics fined over unit&#39;s misleading performance metric\" data-tweet=\"$NVLN $NVLNF - Novelion Therapeutics fined over unit&#39;s misleading performance metric https://seekingalpha.com/news/3297167-novelion-therapeutics-fined-over-units-misleading-performance-metric?source=tweet\" data-url=\"https://seekingalpha.com/news/3297167-novelion-therapeutics-fined-over-units-misleading-performance-metric\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297165\" data-ts=\"1506104498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNC\" target=\"_blank\">CNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297165-healthcare-sector-erases-losses-mccain-just-doomed-obamacare-repeal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare sector erases losses as McCain just doomed Obamacare repeal</a></h4><ul><li>The Health Care SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>) had been in the red this session, but it's returned to flat after the Arizona Senator says he won't vote for Graham-Cassidy. The GOP could theoretically still pass the bill, but that would require getting \"yes\" votes from two of three from the Collins, Murkowski, and Paul trio.</li><li><a href=\"https://seekingalpha.com/news/3297162-hospital-stocks-spike-mccain-thumbs-repeal-obamacare\" target=\"_blank\">Hospital names are moving higher</a>, and insurers as well (some remain in red, but are well off lows). Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color='green'>+2.4%</font>), Molina (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color='green'>+5.2%</font>), UnitedHealth (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='red'>-1%</font>), WellCare (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color='green'>+0.7%</font>), Aetna (<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a> <font color='green'>+0.1%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color='green'>+0.2%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='green'>+0.1%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/VHT' title='Vanguard Health Care ETF'>VHT</a>, <a href='https://seekingalpha.com/symbol/IYH' title='iShares U.S. Healthcare ETF'>IYH</a>, <a href='https://seekingalpha.com/symbol/HQH' title='Tekla Healthcare Investors'>HQH</a>, <a href='https://seekingalpha.com/symbol/CURE' title='Direxion Daily Healthcare Bull 3x Shares ETF'>CURE</a>, <a href='https://seekingalpha.com/symbol/THQ' title='Tekla Healthcare Opportunities Fund'>THQ</a>, <a href='https://seekingalpha.com/symbol/FHLC' title='Fidelity MSCI Health Care Index ETF'>FHLC</a>, <a href='https://seekingalpha.com/symbol/FXH' title='First Trust Health Care AlphaDEX ETF'>FXH</a>, <a href='https://seekingalpha.com/symbol/RXL' title='ProShares Ultra Health Care ETF'>RXL</a>, <a href='https://seekingalpha.com/symbol/RYH' title='Invesco S&P Equal Weight Health Care ETF'>RYH</a>, <a href='https://seekingalpha.com/symbol/RXD' title='ProShares UltraShort Health Care ETF'>RXD</a>, <a href='https://seekingalpha.com/symbol/SICK' title='Daily Healthcare Bear 3x Shares ETF'>SICK</a>, <a href='https://seekingalpha.com/symbol/LNGR' title='Global X Longevity Thematic ETF'>LNGR</a>, <a href='https://seekingalpha.com/symbol/BTEC' title='Principal Healthcare Innovators Index ETF'>BTEC</a>, <a href='https://seekingalpha.com/symbol/JHMH' title='John Hancock Multifactor Healthcare ETF'>JHMH</a>, <a href='https://seekingalpha.com/symbol/HCRF' title='iShares Edge MSCI Multifactor Healthcare ETF'>HCRF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297165\" data-linked=\"Healthcare sector erases losses as McCain just doomed Obamacare repeal\" data-tweet=\"$CNC $XLV $CNC - Healthcare sector erases losses as McCain just doomed Obamacare repeal https://seekingalpha.com/news/3297165-healthcare-sector-erases-losses-mccain-just-doomed-obamacare-repeal?source=tweet\" data-url=\"https://seekingalpha.com/news/3297165-healthcare-sector-erases-losses-mccain-just-doomed-obamacare-repeal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297163\" data-ts=\"1506104002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297163-finish-line-roars-back-after-earnings-stumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finish Line roars back after earnings stumble</a></h4><ul> <li>It's a wild comeback ride for shares of Finish Line (<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a> <font color='green'>+3.8%</font>) after the retailer's slashed guidance initially sent investors to the exit door.</li> <li>Wells Fargo analyst Tom Nikic has a detailed <a href=\"http://www.barrons.com/articles/finish-line-why-no-news-is-good-news-1506096038\" target=\"_blank\">explanation</a> for the turnaround.</li> <li>\"For those looking for silver linings in a choppy print, we'd point out that the guidance reiteration suggests that at least things haven't gotten any worse in September, inventories were down -7% on an owned basis, the company ended the quarter with cash of $115 million (roughly 30% of the market cap) and there is new innovation coming to the sneaker market that optimists can hang their hat on (more Vapormax including kids styles, upgraded Air Force 1 styles, new Nike NBA apparel, etc.),\" he writes.</li> <li>Shares of Finish Line are up 39% from the 52-week low of $6.90 struck in late August.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297066-finish-lines-q2-results\" target=\"_blank\">More on Finish Line's Q2 results</a> (Sept. 22)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297062-finish-line-eps-line-misses-revenue\" target=\"_blank\">Finish Line EPS in-line, misses on revenue</a> (Sept. 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297163\" data-linked=\"Finish Line roars back after earnings stumble\" data-tweet=\"$FINL - Finish Line roars back after earnings stumble https://seekingalpha.com/news/3297163-finish-line-roars-back-after-earnings-stumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3297163-finish-line-roars-back-after-earnings-stumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297164\" data-ts=\"1506104002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297164-pandoraplus-1_5-sirius-xm-wraps-480m-investment-joins-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +1.5% as Sirius XM wraps $480M investment, joins board</a></h4><ul>   <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color='green'>up 1.5%</font> after word that Sirius XM (<a href=\"http://seekingalpha.com/symbol/SIRI\" target=\"_blank\">SIRI</a> <font color='green'>+0.6%</font>) has <a href=\"https://seekingalpha.com/pr/16948706-siriusxm-completes-480-million-strategic-investment-pandora\" target=\"_blank\">closed on its $480M strategic investment</a> in Pandora.</li>    <li>Sirius had bought $172.5M of Series A preferred stock in Pandora when the two executed their agreement June 9, and today it has bought $307.5M more.</li>    <li>The moves puts three Sirius XM execs on Pandora's board: Chairman Greg Maffei (also now chairman of Pandora), CEO James Meyer, and CFO David Frear.</li>    <li>That preferred stock is convertible into common stock at $10.50/share, and bears a 6% cumulative dividend payable in a combination of cash and accretion of the preferred stock. And the preferred stock represents a stake of 19% of currently outstanding shares.</li>    <li>Elizabeth Nelson is leaving Pandora's board effective immediately, bringing the board size to nine members.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297164\" data-linked=\"Pandora +1.5% as Sirius XM wraps $480M investment, joins board\" data-tweet=\"$P $P $SIRI - Pandora +1.5% as Sirius XM wraps $480M investment, joins board https://seekingalpha.com/news/3297164-pandoraplus-1_5-sirius-xm-wraps-480m-investment-joins-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3297164-pandoraplus-1_5-sirius-xm-wraps-480m-investment-joins-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297162\" data-ts=\"1506103323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYH\" target=\"_blank\">CYH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297162-hospital-stocks-spike-on-mccain-thumbs-down-on-repeal-of-obamacare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital stocks spike on McCain thumbs down on repeal of Obamacare</a></h4><ul><li>Hospital operators perk up after Senator John McCain said he would not vote for the Graham Cassidy bill (repeal/replace the Affordable Care Act), adding doubt that the GOP has the votes to pass.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+1.9%</font>)(<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+2.9%</font>)(<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/SEM' title='Select Medical Holdings Corporation'>SEM</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+1.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297162\" data-linked=\"Hospital stocks spike on McCain thumbs down on repeal of Obamacare\" data-tweet=\"$CYH $CYH $LPNT - Hospital stocks spike on McCain thumbs down on repeal of Obamacare https://seekingalpha.com/news/3297162-hospital-stocks-spike-on-mccain-thumbs-down-on-repeal-of-obamacare?source=tweet\" data-url=\"https://seekingalpha.com/news/3297162-hospital-stocks-spike-on-mccain-thumbs-down-on-repeal-of-obamacare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>414&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297161\" data-ts=\"1506103278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297161-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FMSA' title='Fairmount Santrol, Inc.'>FMSA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/GNE' title='Genie Energy Ltd.'>GNE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SQM' title='Chemical & Mining Co. of Chile Inc.'>SQM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297161\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$ANW $FMSA $YUMA - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3297161-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297161-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297155\" data-ts=\"1506102212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297155-oragenics-up-move-fails-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics up move fails, shares down 14%</a></h4><ul><li>Thinly traded nano cap Oragenics (<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='red'>-13.7%</font>) completes a round trip and then some. Shares were up&nbsp;<font color='green'>89%</font>&nbsp;in the session before retracing.</li><li>The company's lead candidate is Phase 2-stage AG013 for the treatment of oral mucositis.</li><li>At the end of June, it had $4M in quick assets while six-month cash flow from operations was&nbsp;<font color='red'>-$3.7M</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297155\" data-linked=\"Oragenics up move fails, shares down 14%\" data-tweet=\"$OGEN - Oragenics up move fails, shares down 14% https://seekingalpha.com/news/3297155-oragenics-up-move-fails-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3297155-oragenics-up-move-fails-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297152\" data-ts=\"1506101316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDS\" target=\"_blank\">DDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297152-dillards-spikes-rumor-mill-grinds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dillard&#39;s spikes as rumor mill grinds</a></h4><ul> <li>The rumor mill is churning out some talk on a plan by Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>) to go private.</li> <li>There's nothing concrete for investors to go on yet, but shares of Dillard's are&nbsp;<font color='green'>up 4.41%</font>&nbsp;on a significant volume spike.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3297152\" data-linked=\"Dillard&#39;s spikes as rumor mill grinds\" data-tweet=\"$DDS - Dillard&#39;s spikes as rumor mill grinds https://seekingalpha.com/news/3297152-dillards-spikes-rumor-mill-grinds?source=tweet\" data-url=\"https://seekingalpha.com/news/3297152-dillards-spikes-rumor-mill-grinds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297149\" data-ts=\"1506100019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297149-tim-cook-thrilled-iphone-watch-launch-day-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tim Cook &quot;thrilled&quot; with iPhone, Watch launch day sales</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) CEO Tim Cook tells <a href=\"https://www.cnbc.com/2017/09/22/apple-ceo-tim-cook-iphone-8-and-apple-watch-series-3-are-sold-out-in-some-places.html\" target=\"_blank\">CNBC</a> he&rsquo;s &ldquo;thrilled&rdquo; during his traditional launch day stop at an Apple Store. &nbsp;</li><li>        Cook says the LTE Apple Watch 3 has &ldquo;sold out in so many places around the world&rdquo; and that the iPhone 8 and 8 Plus are sold out in some locations &ldquo;but we&rsquo;ve got good supply there.&rdquo;</li><li>               Cook also confirmed that the Watch connectivity issue is a software issue fixable with an update and that the issue hasn&rsquo;t hurt sales of the device. &nbsp;&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 1.35%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3296567-apple-issues-statement-watch-cellular-connection-issues\" target=\"_blank\">Apple issues statement on Watch cellular connection issues</a> (Sept. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297149\" data-linked=\"Tim Cook &quot;thrilled&quot; with iPhone, Watch launch day sales\" data-tweet=\"$AAPL - Tim Cook &quot;thrilled&quot; with iPhone, Watch launch day sales https://seekingalpha.com/news/3297149-tim-cook-thrilled-iphone-watch-launch-day-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3297149-tim-cook-thrilled-iphone-watch-launch-day-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297148\" data-ts=\"1506099739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297148-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MSB' title='Mesabi Trust'>MSB</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/UFCS' title='United Fire Group'>UFCS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CIA' title='Citizens, Inc.'>CIA</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297148\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MSB $UFCS $GROW - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3297148-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297148-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297144\" data-ts=\"1506098882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297144-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+72%</font>. <a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/QUAD' title='Quad/Graphics, Inc.'>QUAD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ARLZ-OLD' title='Aralez Pharmaceuticals Inc.'>ARLZ-OLD</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='red'>-86%</font>. <a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PZRX' title='PhaseRx'>PZRX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297144\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IZEA $ASND $ARDM - Midday Gainers / Losers https://seekingalpha.com/news/3297144-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3297144-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297142\" data-ts=\"1506097567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297142-exelixis-resumes-down-move-shares-off-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelixis resumes down move, shares off 13%</a></h4><ul><li>The selloff in Exelixis (<a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-13.1%</font>) resumes after a short-lived rally on double normal volume. Investors are heading to the exits on the heels of the <a href=\"http://www.barrons.com/articles/exelixis-ceo-cfo-sell-11-million-in-stock-1505900236\" target=\"_blank\">news </a>that insiders have sold $15M of stock, including $11M by the CEO and CFO.</li><li>Shares plummeted earlier this month after Bristol-Myers Squibb reported positive late stage results for Optivo + Yervoy in RCC patients, the same turf as Exelixis' CABOMETYX.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294186-exelixis-9-percent-bristol-myers-successful-study-opdivo-yervoy-rcc\" target=\"_blank\">Exelixis down 9% on Bristol-Myers' successful study of Opdivo + Yervoy in RCC</a> (Sept. 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297142\" data-linked=\"Exelixis resumes down move, shares off 13%\" data-tweet=\"$EXEL - Exelixis resumes down move, shares off 13% https://seekingalpha.com/news/3297142-exelixis-resumes-down-move-shares-off-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3297142-exelixis-resumes-down-move-shares-off-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297141\" data-ts=\"1506096799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IP\" target=\"_blank\">IP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297141-international-paper-to-invest-300m-to-add-capacity-alabama-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Paper to invest $300M to add capacity at Alabama plant</a></h4><ul>     <li>International Paper (<a href='https://seekingalpha.com/symbol/IP' title='International Paper Co.'>IP</a> <font color='red'>-2.3%</font>) and peers are lower following news of the company's <a href=\"https://www.bizjournals.com/memphis/news/2017/09/22/ip-investing-300m-for-conversion-at-alabama-mill.html\" target=\"_blank\">investment in an Alabama paper mill</a>.</li>     <li>IP plans to invest $300M to convert its No. 15 paper machine at the Riverdale Mill in Selma, Ala., from uncoated freesheet to high quality whitetop linerboard and  containerboard, adding 450K tons of annual capacity with flexibility to shift between containerboard products.</li>     <li>Shares of WestRock (<a href='https://seekingalpha.com/symbol/WRK' title='WestRock Company'>WRK</a> <font color='red'>-3.2%</font>), Packaging Corp. of America (<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation Of America'>PKG</a> <font color='red'>-2.5%</font>) and Kapstone Paper (<a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a> <font color='red'>-4.1%</font>) all are sharply lower.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297141\" data-linked=\"International Paper to invest $300M to add capacity at Alabama plant\" data-tweet=\"$IP $IP $WRK - International Paper to invest $300M to add capacity at Alabama plant https://seekingalpha.com/news/3297141-international-paper-to-invest-300m-to-add-capacity-alabama-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3297141-international-paper-to-invest-300m-to-add-capacity-alabama-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297134\" data-ts=\"1506096393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVA\" target=\"_blank\">DVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297134-davita-under-pressure-on-sirf-report-on-patient-co-pay-scheme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DaVita under pressure on SIRF report on patient co-pay scheme</a></h4><ul><li>DaVita (<a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a> <font color='red'>-5.8%</font>) is in the red on light volume on the heels of a <a href=\"http://sirf-online.org/2017/09/22/davita-inc-warren-and-charlies-excellent-insurance-gambit/\" target=\"_blank\">report </a>by the Southern Investigative Reporting Foundation &#40;SIRF&#41; that details its use of a non-profit vehicle to fund co-pays from certain privately insured dialysis patients aimed at boosting reimbursement. The scheme, previously reported from different sources, involves a charity called the American Kidney Fund &#40;AKF&#41;, to which the company makes financial contributions are are used to fund co-pay expenses.</li><li>The company has refused to disclose the impact of the scheme on earnings, behavior that SIRF says invites scrutiny. It cites an exchange between CEO Kent Thiry and an analyst at the company's Analyst/Investor Day in May. When asked how much revenue the company generates through AKF's Health Insurance Payment Program, Mr. Thiry said, \"We're not [and] have not and it would not be in your best interest for us to start providing all sorts of detail on that other chunk.\"</li><li>SIRF estimates that AKF support is a factor in 40 - 45% of the company's Kidney Care unit's EBIT, almost $340M in H1.</li><li>SIRF says the company regards its report and questions \"biased\" but has yet to elaborate on what aspects are incorrect.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a> <font color='red'>-0.7%</font>)(<a href='https://seekingalpha.com/symbol/ARA' title='American Renal Associates Holdings'>ARA</a> <font color='red'>-3.3%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3272058-chanos-bearish-dialysis-companies-unsustainability-obamacare-covered-patient-mix\" target=\"_blank\">Chanos bearish on dialysis companies on unsustainability of Obamacare-covered patient mix</a> (June 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3234005-davita-announces-dialysis-patients-suit-acknowledges-subpoena\" target=\"_blank\">DaVita announces dialysis patients' suit; acknowledges subpoena</a> (Jan. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297134\" data-linked=\"DaVita under pressure on SIRF report on patient co-pay scheme\" data-tweet=\"$DVA $DVA $FMS - DaVita under pressure on SIRF report on patient co-pay scheme https://seekingalpha.com/news/3297134-davita-under-pressure-on-sirf-report-on-patient-co-pay-scheme?source=tweet\" data-url=\"https://seekingalpha.com/news/3297134-davita-under-pressure-on-sirf-report-on-patient-co-pay-scheme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297139\" data-ts=\"1506096085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297139-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/STRT' title='Strattec Security Corporation'>STRT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/DSWL' title='Deswell Industries, Inc.'>DSWL</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/KOSS' title='Koss Corporation'>KOSS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297139\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$WATT $STRT $DSWL - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3297139-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297139-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297136\" data-ts=\"1506095783\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297136-vr-gaming-needs-competition-says-runaway-leader-sony\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VR gaming needs competition, says runaway leader Sony</a></h4><ul>   <li>Virtual reality gaming <a href=\"https://www.reuters.com/article/us-htc-m-a-google/at-smartphone-pioneer-htc-a-new-or-virtual-reality-idUSKCN1BX1MN\" target=\"_blank\">needs more competition</a>, says Sony (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='red'>-0.1%</font>) -- which itself is uncomfortable with its large lead in the nascent sector.</li>    <li>The company's PlayStation VR system has built a large lead over HTC's Vive and Oculus Rift (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-0.4%</font>) thanks in part to its massive PlayStation user base, but more competition will drive adoption of VR and spur more development, says Sony Interactive Entertainment CEO Andrew House.</li>    <li>&ldquo;With such a brand new category you want a variety of platforms all doing well to create that rising tide and create the audience,\" he says.</li>    <li>In the quarter ended in June, the company sold more than 500,000 headsets. Sony's gaming business is headed toward its highest ever annual operating profit, of &yen;180B (about $1.6B).</li>    <li>And despite the <a href=\"https://seekingalpha.com/news/3295635-videogame-sales-take-pre-holiday-breather-falling-2-percent\" target=\"_blank\">success of the Nintendo Switch</a> (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='red'>-2.1%</font>), which has given a boost to industry hardware sales, House says the company isn't seeing an impact on PlayStation sales.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297136\" data-linked=\"VR gaming needs competition, says runaway leader Sony\" data-tweet=\"$SNE $SNE $FB - VR gaming needs competition, says runaway leader Sony https://seekingalpha.com/news/3297136-vr-gaming-needs-competition-says-runaway-leader-sony?source=tweet\" data-url=\"https://seekingalpha.com/news/3297136-vr-gaming-needs-competition-says-runaway-leader-sony\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297135\" data-ts=\"1506094948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297135-tariff-seen-likely-commission-rules-u-s-firms-harmed-solar-panel-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tariff seen likely as commission rules U.S. firms harmed by solar panel imports</a></h4><ul>     <li>The International Trade Commission, as expected, determines that U.S. solar panel producers are <a href=\"https://www.bloomberg.com/news/articles/2017-09-22/itc-votes-in-favor-of-imposing-tariffs-on-u-s-solar-imports\" target=\"_blank\">harmed by cheap imports</a>; Pres. Trump will recommend remedies against import surges by Nov. 13 to address the situation, and he is <a href=\"https://www.axios.com/trump-seen-likely-to-issue-solar-tariffs-2482723685.html\" target=\"_blank\">widely believed to favor tariffs</a>.</li>     <li>First Solar (<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a> <font color='green'>+5.5%</font>) surges in reaction to the ruling, as it is viewed as the biggest winner given its low cost advantage.</li>     <li>Tariffs would be a negative for Chinese solar names including Jinko Solar (<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-1.7%</font>) and Canadian Solar (<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='red'>-2.8%</font>), and residential solar providers such as Sunrun (<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='green'>+0.6%</font>), Vivint Solar (<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='red'>-5.9%</font>), SunPower (<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+0.8%</font>), SolarEdge (<a href='https://seekingalpha.com/symbol/SEDG' title='SolarEdge Technologies'>SEDG</a> <font color='green'>+1.5%</font>) and Enphase Energy (<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='red'>-4.3%</font>) could suffer higher costs for solar panels they purchase.</li>     <li>ETFs:&nbsp;<a href='https://seekingalpha.com/symbol/TAN' title='Invesco Solar Portfolio ETF'>TAN</a>, <a href='https://seekingalpha.com/symbol/KWT' title='VanEck Vectors Solar Energy ETF'>KWT</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3297135\" data-linked=\"Tariff seen likely as commission rules U.S. firms harmed by solar panel imports\" data-tweet=\"$FSLR $FSLR $JKS - Tariff seen likely as commission rules U.S. firms harmed by solar panel imports https://seekingalpha.com/news/3297135-tariff-seen-likely-commission-rules-u-s-firms-harmed-solar-panel-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3297135-tariff-seen-likely-commission-rules-u-s-firms-harmed-solar-panel-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>84&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297131\" data-ts=\"1506093435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWEN\" target=\"_blank\">CWEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297131-nrg-yield-pops-after-report-says-hiring-bankers-to-evaluate-strategic-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NRG Yield pops after report says hiring bankers to evaluate strategic options</a></h4><ul>     <li>NRG Yield (NYLD <font color='green'>+2.9%</font>) is higher following a SparkSpread report that the yieldco has retained J.P. Morgan and Barclays to  <a href=\"https://www.streetinsider.com/Mergers+and+Acquisitions/NRG+Yield+%28NYLD%29+Retains+Advisers+to+Review+Strategic+Alternatives+-+SparkSpread/13320212.html\" target=\"_blank\">review strategic alternatives</a> for its publicly traded shares.</li><li>The report says Citi also is running a sale process for NRG Energy's (<a href='https://seekingalpha.com/symbol/NRG' title='NRG Energy, Inc.'>NRG</a> <font color='red'>-0.5%</font>) Class B and D shares in the yieldco; NRG has said previously that it planned to sell some or all of its interest in NYLD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297131\" data-linked=\"NRG Yield pops after report says hiring bankers to evaluate strategic options\" data-tweet=\"$CWEN $CWEN $NRG - NRG Yield pops after report says hiring bankers to evaluate strategic options https://seekingalpha.com/news/3297131-nrg-yield-pops-after-report-says-hiring-bankers-to-evaluate-strategic-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3297131-nrg-yield-pops-after-report-says-hiring-bankers-to-evaluate-strategic-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297128\" data-ts=\"1506092711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297128-steel-tariff-decision-to-wait-until-after-tax-bill-commerce-secretary-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel tariff decision to wait until after tax bill, Commerce Secretary says</a></h4><ul>     <li>The Trump administration will <a href=\"https://www.bloomberg.com/news/articles/2017-09-22/ross-signals-delay-on-steel-decision-as-trump-pushes-tax-reform\" target=\"_blank\">defer a decision on steel tariffs</a> as it focuses on getting tax reforms through Congress, Commerce Secretary Ross tells Bloomberg.</li>     <li>Ross says he will offer Pres. Trump a range of options when it reports its findings on the Section 232 steel investigation, but overhauling the tax system is the &ldquo;single most important\" item on the administration&rsquo;s agenda.</li>     <li>Shares of major U.S. steelmakers are broadly lower: U.S. Steel, which also was <a href=\"https://seekingalpha.com/news/3297081-u-s-steel-arcelormittal-cut-cowen-global-steel-iron-ore-price-seen-lower\" target=\"_blank\">downgraded</a> at Cowen, fell by as much as 6%, while Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-0.2%</font>), AK Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-3.9%</font>) and Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-0.7%</font>) also are down.</li><li>ETF: <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3297128\" data-linked=\"Steel tariff decision to wait until after tax bill, Commerce Secretary says\" data-tweet=\"$NUE $NUE $AKS - Steel tariff decision to wait until after tax bill, Commerce Secretary says https://seekingalpha.com/news/3297128-steel-tariff-decision-to-wait-until-after-tax-bill-commerce-secretary-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3297128-steel-tariff-decision-to-wait-until-after-tax-bill-commerce-secretary-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297126\" data-ts=\"1506092460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297126-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='green'>+12%</font>. ETRM <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='red'>-86%</font>. <a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CYCC' title='Cyclacel Pharmaceuticals, Inc.'>CYCC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ONS-OLD' title='Oncobiologics'>ONS-OLD</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297126\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$ASND $ARDM $MRNS - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3297126-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3297126-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297122\" data-ts=\"1506091517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YOGA\" target=\"_blank\">YOGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297122-yogaworks-lower-after-revenue-falls-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YogaWorks lower after revenue falls off</a></h4><ul>     <li>YogaWorks (<a href='https://seekingalpha.com/symbol/YOGA' title='YogaWorks'>YOGA</a> <font color='red'>-2.2%</font>) trades lower after it shows a 6%&nbsp;drop in revenue with its first earnings report posted since the company's IPO.</li>     <li>The yoga studio operator's EBITDA loss of $551K was less than the $569K estimated by analysts.</li>     <li>\"Following our IPO, we have the capital in place and are well positioned, as the acquirer of choice within the large and highly fragmented yoga industry, to execute our growth plan of acquiring premier studios,\" says CEO Rosanna McCollough.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3296983-yogaworks-reports-q2-results\" target=\"_blank\">YogaWorks reports Q2 results</a> (Sept. 21)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297122\" data-linked=\"YogaWorks lower after revenue falls off\" data-tweet=\"$YOGA - YogaWorks lower after revenue falls off https://seekingalpha.com/news/3297122-yogaworks-lower-after-revenue-falls-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3297122-yogaworks-lower-after-revenue-falls-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297120\" data-ts=\"1506091124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRHM\" target=\"_blank\">CRHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297120-crh-sees-lower-q3-revenues-due-to-hurricane-irma-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRH sees lower Q3 revenues due to Hurricane Irma; shares down 4%</a></h4><ul><li>CRH Medical (<a href='https://seekingalpha.com/symbol/CRHM' title='CRH Medical Corp.'>CRHM</a> <font color='red'>-3.8%</font>) <a href=\"https://seekingalpha.com/pr/16948488-crh-medical-corporation-announces-majority-purchase-anesthesia-practice-north-carolina\" target=\"_blank\">updates </a>its Q3 guidance to account for the cancellation of 1,500 procedures due to Hurricane Irma. It now expects revenues of $22.7M and non-GAAP operating EBITDA of $7.3M.</li><li>It also reports that it has completed its acquisition of a 51% stake in a gastroenterology anesthesia practice based in Raleigh, NC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297120\" data-linked=\"CRH sees lower Q3 revenues due to Hurricane Irma; shares down 4%\" data-tweet=\"$CRHM - CRH sees lower Q3 revenues due to Hurricane Irma; shares down 4% https://seekingalpha.com/news/3297120-crh-sees-lower-q3-revenues-due-to-hurricane-irma-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3297120-crh-sees-lower-q3-revenues-due-to-hurricane-irma-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297119\" data-ts=\"1506090790\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGP\" target=\"_blank\">FGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297119-ferrellgas-snags-schwartz-from-mdu-resources-new-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrellgas snags Schwartz from MDU Resources as new CFO</a></h4><ul>     <li>Ferrellgas Partners (<a href='https://seekingalpha.com/symbol/FGP' title='Ferrellgas Partners L.P'>FGP</a> <font color='green'>+3%</font>) selects Doran Schwartz as its <a href=\"https://seekingalpha.com/pr/16948422-ferrellgas-appoints-new-chief-financial-officer\" target=\"_blank\">new CFO</a>, effective Oct. 16, as current CFO Al Heitmann is set to retire on Jan. 31.</li>     <li>Schwartz is <a href=\"https://seekingalpha.com/news/3297012-mdu-resources-names-new-cfo-cao-schwartz-departs\" target=\"_blank\">departing</a> MDU&nbsp;Resources (NYSE:<a href='https://seekingalpha.com/symbol/MDU' title='MDU Resources Group, Inc.'>MDU</a>), where has been VP and CFO since 2010 after holding various financial roles since 2005.</li>     <li>Heitmann will remain with FGP as a special advisor until his anticipated retirement date.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297119\" data-linked=\"Ferrellgas snags Schwartz from MDU Resources as new CFO\" data-tweet=\"$FGP $FGP $MDU - Ferrellgas snags Schwartz from MDU Resources as new CFO https://seekingalpha.com/news/3297119-ferrellgas-snags-schwartz-from-mdu-resources-new-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3297119-ferrellgas-snags-schwartz-from-mdu-resources-new-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297116\" data-ts=\"1506090179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297116-eleven-bio-makes-enough-product-to-complete-late-stage-study-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eleven Bio makes enough product to complete late-stage study; shares up 2%</a></h4><ul><li>Thinly traded nano cap Eleven Biotherapeutics (EBIO <font color='green'>+1.9%</font>) <a href=\"https://seekingalpha.com/pr/16948436-eleven-biotherapeutics-announces-completion-vicinium-manufacturing-ongoing-clinical-trials\" target=\"_blank\">announces </a>that it has manufactured all the Vicinium necessary for its ongoing Phase 3 study in non-muscle invasive bladder cancer and for its CRADA deal with the National Cancer Institute.</li><li>The company says it will now redirect its resources toward completing the trial and preparing a BLA submission to the FDA. The action will include a headcount reduction.</li><li><a href=\"http://www.elevenbio.com/pipeline/vicinium.html\" target=\"_blank\">Vicinium&nbsp;</a>is a recombinant fusion protein designed to specifically target and deliver an anti-cancer payload directly to tumor cells.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271003-eleven-bios-late-stage-study-vicinium-bladder-cancer-continue-planned-shares-10-percent\" target=\"_blank\">Eleven Bio's late-stage study of Vicinium in bladder cancer to continue as planned; shares up 10%</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297116\" data-linked=\"Eleven Bio makes enough product to complete late-stage study; shares up 2%\" data-tweet=\"$SESN - Eleven Bio makes enough product to complete late-stage study; shares up 2% https://seekingalpha.com/news/3297116-eleven-bio-makes-enough-product-to-complete-late-stage-study-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3297116-eleven-bio-makes-enough-product-to-complete-late-stage-study-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297113\" data-ts=\"1506089449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MB\" target=\"_blank\">MB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297113-keybanc-upgrades-mindbody-shares-up-7_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KeyBanc upgrades Mindbody, shares up 7.9%</a></h4><ul><li>        KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/KeyBanc+Upgrades+Mindbody+%28MB%29+to+Overweight/13319226.html\" target=\"_blank\">upgrades</a> Mindbody (NASDAQ:<a href='https://seekingalpha.com/symbol/MB' title='Mindbody'>MB</a>) from Sector Weight to Overweight with a $32 price target.</li><li>                  Analyst Brent Bracelin cites the potential for growth and margin expansion in next year&rsquo;s salon and spa software expansion.    </li><li>               Other tailwinds include Reserve with Google revenues, expanding international payment support, and an expanded footprint overseas.&nbsp;</li><li>                  Analyst forecasts put FY17 EPS at $0.09 and raises FY18 EPS from $0.02 to $0.08.    </li><li>               Mindbody shares are&nbsp;<font color='green'>up 7.9%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297113\" data-linked=\"KeyBanc upgrades Mindbody, shares up 7.9%\" data-tweet=\"$MB - KeyBanc upgrades Mindbody, shares up 7.9% https://seekingalpha.com/news/3297113-keybanc-upgrades-mindbody-shares-up-7_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3297113-keybanc-upgrades-mindbody-shares-up-7_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297111\" data-ts=\"1506088894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FALC\" target=\"_blank\">FALC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297111-falconstor-shares-plunge-on-delisting-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FalconStor shares plunge on delisting news</a></h4><ul><li>FalconStor Software (<a href='https://seekingalpha.com/symbol/FALC' title='FalconStor Software, Inc.'>OTC:FALC</a>)&nbsp;<font color='red'>plunges 25.31%&nbsp;</font>after <a href=\"https://seekingalpha.com/filing/3703452\" target=\"_blank\">announcing</a> Nasdaq will delist the company before the market opens on Monday.</li><li>Nasdaq first warned the company in June but continued the listing after a panel meeting. FalconStor notified Nasdaq this week that the company couldn't meet the requirements of that continuation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297111\" data-linked=\"FalconStor shares plunge on delisting news\" data-tweet=\"$FALC - FalconStor shares plunge on delisting news https://seekingalpha.com/news/3297111-falconstor-shares-plunge-on-delisting-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3297111-falconstor-shares-plunge-on-delisting-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297109\" data-ts=\"1506088668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297109-auris-medical-completes-enrollment-in-late-stage-study-of-keyzilen-in-tinnitus-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris Medical completes enrollment in late-stage study of Keyzilen in tinnitus; shares up 3%</a></h4><ul><li>Thinly traded nano cap Auris Medical (<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='green'>+3.1%</font>) hits the enrollment target in its Phase 3 TACTT3 study assessing Keyzilen in patients with acute and post-acute inner ear tinnitus (perception of constant ringing in the ears). Topline data are expected in Q1 2018.</li><li>An earlier Phase 3, TACTT2, was unsuccessful.</li><li>Keyzilen (<a href=\"http://www.aurismedical.com/product-candidates/am-101\" target=\"_blank\">AM-101</a>)&nbsp;contains esketamine hydrochloride, an N-Methyl-D-aspartate &#40;NMDA&#41;&nbsp;receptor antagonist. It is administered in one treatment cycle consisting of three injections into the middle ear over three to five days. Once injected, the drug diffuses through the round window into the cochlea.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3204202-auris-medicals-lead-product-candidate-flunks-late-stage-study-shares-plummet-42-percent\" target=\"_blank\">Auris Medical's lead product candidate flunks late-stage study; shares plummet 42% premarket</a> (Aug. 18, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297109\" data-linked=\"Auris Medical completes enrollment in late-stage study of Keyzilen in tinnitus; shares up 3%\" data-tweet=\"$EARS - Auris Medical completes enrollment in late-stage study of Keyzilen in tinnitus; shares up 3% https://seekingalpha.com/news/3297109-auris-medical-completes-enrollment-in-late-stage-study-of-keyzilen-in-tinnitus-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3297109-auris-medical-completes-enrollment-in-late-stage-study-of-keyzilen-in-tinnitus-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297106\" data-ts=\"1506088120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMBS\" target=\"_blank\">RMBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297106-jpmorgan-downgrades-rambus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan downgrades Rambus</a></h4><ul><li>        JPMorgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Rambus+Inc.+%28RMBS%29+to+Neutral/13319219.html\" target=\"_blank\">downgrades</a> Rambus (NASDAQ:<a href='https://seekingalpha.com/symbol/RMBS' title='Rambus, Inc.'>RMBS</a>) from Overweight to Neutral with a $15 price target.</li><li>               Analyst Paul Coster says the company has a lack of upcoming catalysts and the long-term outlook remains &ldquo;largely unchanged&rdquo;.</li><li>               Coster says Rambus currently trades at 20.2x his CY17 pro forma EPS of $0.66. His FY18 EPS estimate stays at $0.74 but the FY19 estimate rises one cent to $0.80. &nbsp;&nbsp;</li><li>               Rambus shares are&nbsp;<font color='red'>down 1.91%</font>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297106\" data-linked=\"JPMorgan downgrades Rambus\" data-tweet=\"$RMBS - JPMorgan downgrades Rambus https://seekingalpha.com/news/3297106-jpmorgan-downgrades-rambus?source=tweet\" data-url=\"https://seekingalpha.com/news/3297106-jpmorgan-downgrades-rambus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297101\" data-ts=\"1506086715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297101-grubhubminus-4_4-amazon-partners-olo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GrubHub -4.4% as Amazon partners with Olo</a></h4><ul>   <li>Food-delivery specialist GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) is <font color='red'>4.4% lower</font> premarket after word of Amazon.com's <a href=\"https://seekingalpha.com/news/3297099-olo-announces-amazon-restaurants-partnership\" target=\"_blank\">parrtnership with Olo</a>, which could let it press deep into GrubHub's delivery market space.</li>    <li>That would be a monthlong low for GrubHub, quoting at its lowest price since Aug. 3.</li>    <li>While Buca di Beppo is the only Olo customer so far to say it will be using Amazon Restaurants for delivery, dozens of other brands could follow, including Chipotle Mexican Grill and Shake Shack.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297101\" data-linked=\"GrubHub -4.4% as Amazon partners with Olo\" data-tweet=\"$GRUB - GrubHub -4.4% as Amazon partners with Olo https://seekingalpha.com/news/3297101-grubhubminus-4_4-amazon-partners-olo?source=tweet\" data-url=\"https://seekingalpha.com/news/3297101-grubhubminus-4_4-amazon-partners-olo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297100\" data-ts=\"1506086708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASND\" target=\"_blank\">ASND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297100-versartis-vrsminus-317-stumble-propels-ascendis-shares-ahead-45-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Versartis VRS-317 stumble propels Ascendis; shares ahead 45% premarket</a></h4><ul><li>Thinly traded Ascendis Pharma A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a>) is up&nbsp;<font color='green'>45%</font>&nbsp;premarket on increased volume in response to Versartis' (NASDAQ:<a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a>) failed Phase 3 clinical trial of VRS-317 in pediatric growth hormone deficiency.</li><li>Ascendis' lead candidate is TransCon Growth Hormone for the same indication. A <a href=\"https://clinicaltrials.gov/ct2/show/NCT02781727?term=ascendis&amp;rank=3\" target=\"_blank\">Phase 3 study</a> comparing it to Pfizer's Genotropin is in process. According to ClinicalTrials.gov, the estimated primary completion date is November 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3202573-ascendis-pharma-commences-late-stage-study-supporting-lead-product-candidate\" target=\"_blank\">Ascendis Pharma commences late-stage study supporting lead product candidate</a> (Aug. 11, 2016)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297008-versartis-lead-candidate-vrsminus-317-flunks-late-stage-study-shares-poised-significant-drop\" target=\"_blank\">Versartis' lead candidate VRS-317 flunks late-stage study; shares poised for significant drop</a> (Sept. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297100\" data-linked=\"Versartis VRS-317 stumble propels Ascendis; shares ahead 45% premarket\" data-tweet=\"$ASND $ASND $VSAR-OLD - Versartis VRS-317 stumble propels Ascendis; shares ahead 45% premarket https://seekingalpha.com/news/3297100-versartis-vrsminus-317-stumble-propels-ascendis-shares-ahead-45-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297100-versartis-vrsminus-317-stumble-propels-ascendis-shares-ahead-45-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297098\" data-ts=\"1506086153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297098-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a> <font color='green'>+45%</font>.</li><li><a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297069-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+6%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3297069-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a>&nbsp;analyst action.</li><li><a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297098\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ASND $SVRA $AKTX - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3297098-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3297098-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297096\" data-ts=\"1506085898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297096-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a>&nbsp;<font color='red'>-85%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297008-versartis-lead-candidate-vrsminus-317-flunks-late-stage-study-shares-poised-significant-drop\" target=\"_blank\">announcing</a> Phase 3 VELOCITY trial of Somavaratan in pediatric growth hormone deficiency not meeting primary endpoint.</li><li><a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297062-finish-line-eps-line-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3297096\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$VSAR-OLD $FINL $ICPT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3297096-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3297096-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297095\" data-ts=\"1506085862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TAHO\" target=\"_blank\">TAHO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297095-tahoe-resourcesplus-4-after-raising-gold-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tahoe Resources +4% after raising gold production guidance</a></h4><ul>     <li>Tahoe Resources (NYSE:<a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a>)&nbsp;<font color='green'>+4.4%</font> premarket after <a href=\"https://seekingalpha.com/pr/16948291-tahoe-revises-2017-guidance-gold-operations-provides-updated-reserves-resources-timmins-west\" target=\"_blank\">raising guidance</a> for FY 2017 gold production to 400K-450K oz. from its previous outlook of 375K-425K, helped by a positive mine plan reconciliation at the La Arena mine in Peru.</li>     <li>TAHO says it will begin a drilling program in Q4 to better define the mineralization below the Calaorco pit with the goal of  extending La Arena's mine life.</li>     <li>TAHO expects expansion projects at Shahuindo and Bell Creek will increase production to more than 500K oz./year beginning in 2019, and it updates estimated measured and indicated mineral resources at the Timmins West Mine in Canada to 1.02M oz.</li>     <li>The miner also lowers estimated all-in sustaining costs to $1,050-$1,150/oz. from $1,150-$1,250/oz. earlier, driven by higher production and lower capital and exploration costs.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297095\" data-linked=\"Tahoe Resources +4% after raising gold production guidance\" data-tweet=\"$TAHO - Tahoe Resources +4% after raising gold production guidance https://seekingalpha.com/news/3297095-tahoe-resourcesplus-4-after-raising-gold-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3297095-tahoe-resourcesplus-4-after-raising-gold-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297093\" data-ts=\"1506085776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297093-car-max-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Car Max higher on earnings beat</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a>) reports used vehicles unit sales rose 11.1% to 186,019, and +5.3% on a comparable-store basis&nbsp;in <a href=\"https://seekingalpha.com/pr/16948425-carmax-reports-second-quarter-results\" target=\"_blank\">Q2</a>.</li><li>Used vehicle sales advanced 11.9% to $3.69B.</li><li>Total wholesale vehicle unit sales grew 0.4% to 105,508 and total sales down 2.3% to $547.8M.</li><li>CarMax Auto Finance income expanded 12.5% to $107.9M.</li><li>Average selling prices: Used vehicles: $19,667 (+0.7%), Wholesale vehicles: $4,957 (-3.2%).</li><li>Gross margin rate improved 20 bps to 13.8%.</li><li>Gross profit per used vehicle increased 0.8% to $2,178.</li><li>Gross profit per wholesale&nbsp;vehicle +9.2% to $950.</li><li>KMX&nbsp;<font color='green'>+3.86%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297093\" data-linked=\"Car Max higher on earnings beat\" data-tweet=\"$KMX - Car Max higher on earnings beat https://seekingalpha.com/news/3297093-car-max-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3297093-car-max-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297092\" data-ts=\"1506085485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297092-delcath-inks-deal-convertible-debt-holders-for-short-term-operating-capital-reverse-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath inks deal with convertible debt holders for short-term operating capital, reverse stock split to proceed</a></h4><ul><li>In a <a href=\"https://seekingalpha.com/pr/16948480-delcath-issues-letter-shareholders\" target=\"_blank\">letter </a>to shareholders, Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a>) CEO Jennifer Simpson reports that the company has inked an agreement with holders of its 2016 convertible notes to exchange the notes for preferred shares and $500K in cash, providing the company with short-term operating capital.</li><li>The company also obtained consent from two shareholders that authorizes the board to institute a reverse stock split at either 1:50, 1:100 or 1:350, at the board's discretion. The reverse split will be approved once 20 calendar days have passed from the mailing date of the Schedule 14C Information Statement to shareholders.</li><li>She says the actions are necessary for company to access additional capital and continue operations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297092\" data-linked=\"Delcath inks deal with convertible debt holders for short-term operating capital, reverse stock split to proceed\" data-tweet=\"$DCTH - Delcath inks deal with convertible debt holders for short-term operating capital, reverse stock split to proceed https://seekingalpha.com/news/3297092-delcath-inks-deal-convertible-debt-holders-for-short-term-operating-capital-reverse-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3297092-delcath-inks-deal-convertible-debt-holders-for-short-term-operating-capital-reverse-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297091\" data-ts=\"1506085479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297091-piper-jaffray-increases-apple-price-target-and-asp-forecast-iphone-8-launches-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray increases Apple price target and ASP forecast; iPhone 8 launches today</a></h4><ul><li>        Piper Jaffray <a href=\"https://www.cnbc.com/2017/09/22/buy-apple-because-more-expensive-1000-iphone-x-will-boost-its-profit-analyst.html\" target=\"_blank\">raises</a> its Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) price target by $6 to $196 and maintains an Overweight rating.</li><li>               Analyst Michael Olson predicts that the iPhone 8 and iPhone X will boost the company&rsquo;s overall average selling point. Olson forecasts FY18 iPhone ASP of $710 compared to the $696 Street consensus.&nbsp;</li><li>               The ASP increase also adjusts Olson&rsquo;s FY18 EPS estimate from $10.68 to $11.11, compared to $10.89 consensus.&nbsp;</li><li>               Olson writes, &ldquo;We recommend owning Apple on potential for a strong overall iPhone cycle, rising ASPs and a favorable services revenue trajectory.&rdquo;&nbsp;</li><li>               The iPhone 8 and 8 Plus hit retail stores today with the launches in Sydney, Australia, and Asia described as <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwjum5X_67jWAhVJ0iYKHd7-DoYQu4gBCCYoATAA&amp;url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-apple-iphone%2Fapples-iphone-8-launch-in-sydney-sees-bleak-turnout-idUSKCN1BX05Y&amp;usg=AFQjCNHk6xRH_RgTKtTy1T1vyEk7oYlVvg\" target=\"_blank\">&ldquo;bleak&rdquo;</a> and <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwjum5X_67jWAhVJ0iYKHd7-DoYQuogBCCkoBDAA&amp;url=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-apple-iphone%2Fapples-iphone-8-sees-muted-launch-in-asia-idUSKCN1BX05Y&amp;usg=AFQjCNFi2Sdq7wKik3A2IudRK3vOTS34ww\" target=\"_blank\">&ldquo;muted&rdquo;,</a> respectively.&nbsp;</li><li>Apple shares are&nbsp;<font color='red'>down 0.47%&nbsp;</font>premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3296740-raymond-james-apple-begun-final-production-iphone-x\" target=\"_blank\">Raymond James: Apple hasn't begun final production of iPhone X</a> (Sept. 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297091\" data-linked=\"Piper Jaffray increases Apple price target and ASP forecast; iPhone 8 launches today\" data-tweet=\"$AAPL - Piper Jaffray increases Apple price target and ASP forecast; iPhone 8 launches today https://seekingalpha.com/news/3297091-piper-jaffray-increases-apple-price-target-and-asp-forecast-iphone-8-launches-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3297091-piper-jaffray-increases-apple-price-target-and-asp-forecast-iphone-8-launches-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>159&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297086\" data-ts=\"1506084450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297086-deal-talks-said-to-heat-up-sprint-and-t-mobile\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deal talks said to heat up between Sprint and T-Mobile</a></h4><ul> <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) and T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) are on the move after Reuters reports that <a href=\"https://www.reuters.com/article/us-sprint-m-a-tmobile-exclusive/exclusive-t-mobile-sprint-close-to-agreeing-deal-terms-sources-idUSKCN1BX1EK\" target=\"_blank\">deal talks</a> are heating up.</li> <li>Sources indicate a major breakthrough has pushed a merger closer to the finish line.</li> <li>Softbank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group ADR'>OTCPK:SFTBY</a>, <a href='https://seekingalpha.com/symbol/SFTBF' title='SoftBank Group'>OTCPK:SFTBF</a>) is expected to own 40% to 50% of the combined company through its Sprint stake, while Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGF' title='Deutsche Telekom AG'>OTCQX:DTEGF</a>, <a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG ADR'>OTCQX:DTEGY</a>) will hold a majority stake via its T-Mobile holdings.</li><li>Shares of Sprint are&nbsp;<font color='green'>up 3.49%</font>&nbsp;in premarket trading, while T-Mobile is&nbsp;<font color='green'>1.51% higher</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297086\" data-linked=\"Deal talks said to heat up between Sprint and T-Mobile\" data-tweet=\"$S $S $TMUS - Deal talks said to heat up between Sprint and T-Mobile https://seekingalpha.com/news/3297086-deal-talks-said-to-heat-up-sprint-and-t-mobile?source=tweet\" data-url=\"https://seekingalpha.com/news/3297086-deal-talks-said-to-heat-up-sprint-and-t-mobile\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297085\" data-ts=\"1506084449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMP\" target=\"_blank\">CMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297085-compass-minerals-cuts-earnings-view-on-goderich-mine-output-constraints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compass Minerals cuts earnings view on Goderich mine output constraints</a></h4><ul>     <li>Compass Minerals (NYSE:<a href='https://seekingalpha.com/symbol/CMP' title='Compass Minerals International, Inc.'>CMP</a>) <font color='red'>-7.9%</font> premarket after <a href=\"https://seekingalpha.com/pr/16948227-compass-minerals-reports-short-term-production-constraints-goderich-mine\" target=\"_blank\">lowering its FY 2017 EPS guidance</a> to $2.50-$2.80, well below the $3.04 analyst consensus estimate and prior company guidance of $3.00-$3.50.</li>     <li>CMP says the Goderich, Ontario, rock salt mine is operating at reduced rates after geological movements caused a partial ceiling fall on Sept. 18 which damaged part of the mine&rsquo;s main conveyance system; the company expects to return to normal operating rates within six weeks.</li>     <li>CMP also says plant nutrient volumes in Brazil have lagged expectations, which likely will limit Plant Nutrition South America segment sales volumes to the lower end of its guidance range.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297085\" data-linked=\"Compass Minerals cuts earnings view on Goderich mine output constraints\" data-tweet=\"$CMP - Compass Minerals cuts earnings view on Goderich mine output constraints https://seekingalpha.com/news/3297085-compass-minerals-cuts-earnings-view-on-goderich-mine-output-constraints?source=tweet\" data-url=\"https://seekingalpha.com/news/3297085-compass-minerals-cuts-earnings-view-on-goderich-mine-output-constraints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297081\" data-ts=\"1506082854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297081-u-s-steel-arcelormittal-cut-cowen-global-steel-iron-ore-price-seen-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel, ArcelorMittal cut at Cowen as global steel, iron ore price seen lower</a></h4><ul>     <li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='red'>-3.5%</font> premarket after Cowen <a href=\"https://www.streetinsider.com/Analyst+Comments/Cowen+Downgrades+US+Steel+%28X%29+to+Underperform/13319462.html\" target=\"_blank\">downgrades</a> shares to Underperform from Market Perform with a $20 price target, cut from $24, as the firm sees prices for iron ore and U.S. hot rolled coil poised to move lower.</li>     <li>U.S. Steel is heavily exposed to HRC spot market movements in addition to being vertically integrated, and is unable to benefit from a move lower in iron ore prices, Cowen says.</li>     <li>Cowen thinks seasonal production cuts and shrinking credit availability in China <a href=\"https://twitter.com/thenotablecalls/status/911198480458223616\" target=\"_blank\">could pour cold water on steel pricing</a>; 2017 has been the largest stimulus year for China since 2013, yet several economic indicators are well below 2013, the firm says.</li>     <li>Cowen also <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Cowen+Downgrades+Arcelor+Mittal+%28MT%29+to+Market+Perform/13319409.html\" target=\"_blank\">cuts</a> ArcelorMittal (NYSE:<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a>) to Market Perform from Outperform with a $27 price target, trimmed from $32, saying the majority of the company's business segments are heavily leveraged to iron ore prices.</li><li>ETF:&nbsp;<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297081\" data-linked=\"U.S. Steel, ArcelorMittal cut at Cowen as global steel, iron ore price seen lower\" data-tweet=\"$X $X $MT - U.S. Steel, ArcelorMittal cut at Cowen as global steel, iron ore price seen lower https://seekingalpha.com/news/3297081-u-s-steel-arcelormittal-cut-cowen-global-steel-iron-ore-price-seen-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3297081-u-s-steel-arcelormittal-cut-cowen-global-steel-iron-ore-price-seen-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297067\" data-ts=\"1506079378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JUNO\" target=\"_blank\">JUNO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297067-juno-prices-stock-offering-41-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juno prices stock offering at $41; shares up 1% premarket</a></h4><ul><li>Juno Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a>) <a href=\"https://seekingalpha.com/pr/16948318-juno-therapeutics-prices-250-million-follow-offering\" target=\"_blank\">prices</a> its follow-on public offering of 6.1M shares of common stock at $41 per share. Underwriters over-allotment is an additional 915K shares. Closing date is September 26.</li><li>Concurrently, it will execute a private placement of 659,415 common shares at $41 to a subsidiary of Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>).</li><li>Aggregate gross proceeds will be $277.1M ($318.7M if underwriters fully exercise their allotment).</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket. Yesterday's close was $41.62.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297067\" data-linked=\"Juno prices stock offering at $41; shares up 1% premarket\" data-tweet=\"$JUNO $JUNO $CELG - Juno prices stock offering at $41; shares up 1% premarket https://seekingalpha.com/news/3297067-juno-prices-stock-offering-41-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297067-juno-prices-stock-offering-41-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297066\" data-ts=\"1506079047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297066-on-finish-lines-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Finish Line&#39;s Q2 results</a></h4><ul>     <li>Finish Line (NASDAQ:<a href='https://seekingalpha.com/symbol/FINL' title='The Finish Line, Inc.'>FINL</a>) reports comparable-store sales fell 4.5% in <a href=\"https://seekingalpha.com/pr/16948409-finish-line-reports-second-quarter-fiscal-year-2018-results\" target=\"_blank\">Q2</a>.</li>     <li>Finish Line Macy&rsquo;s sales increased 5.6%.</li>     <li>Gross margin rate squeezed 390 bps to 27.8%.</li>     <li>SG&amp;A expense rate rose 190 bps to 25.9%.</li>     <li>Adjusted operating margin rate decreased 590 bps to 1.8%.</li>     <li>Merchandise inventory -11.1% Y/Y to $308.07M.</li>     <li>Store count Y/Y: Finish Line -16 to 569; Branded shops -13 to 378.</li>     <li><b>Q3 Guidance</b>: Comparable-store sales: decrease 3% to 5%; Adjusted EPS: -$0.32 to -$0.40.</li>     <li><b>Q4 Guidance</b>: Comparable-store sales: decrease 3% to 5%; Adjusted EPS: $0.50 to $0.58.</li>     <li><b>FY2018 Guidance</b>: Comparable-store sales: decrease 3% to 5%;&nbsp;Adjusted EPS: $0.50 to $0.60.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297066\" data-linked=\"More on Finish Line&#39;s Q2 results\" data-tweet=\"$FINL - More on Finish Line&#39;s Q2 results https://seekingalpha.com/news/3297066-on-finish-lines-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3297066-on-finish-lines-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297057\" data-ts=\"1506075508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297057-ge-seen-working-deal-to-sell-unit-to-abb\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE seen working deal to sell unit to ABB</a></h4><ul> <li>GE (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) is closing in on a <a href=\"https://www.bloomberg.com/news/articles/2017-09-22/ge-is-said-to-near-industrial-solutions-unit-sale-to-abb-j7vpsvy0\" target=\"_blank\">deal</a> to sell its industrial solutions unit to ABB (NYSE:<a href='https://seekingalpha.com/symbol/ABB' title='ABB LTD.'>ABB</a>), sources tell Bloomberg. An announcement could arrive before next week.</li> <li>The deal is seen going off in the neighborhood of $2.5B to $3.0B.</li> <li>GE <font color='green'>+0.32%</font> premarket to $24.83. ABB <font color='green'>+0.20%</font> premarket to $24.68.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297057\" data-linked=\"GE seen working deal to sell unit to ABB\" data-tweet=\"$GE $GE $ABB - GE seen working deal to sell unit to ABB https://seekingalpha.com/news/3297057-ge-seen-working-deal-to-sell-unit-to-abb?source=tweet\" data-url=\"https://seekingalpha.com/news/3297057-ge-seen-working-deal-to-sell-unit-to-abb\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":50,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}